Business
Park Ha Biological Technology Co., Ltd. Announces Closing of a US$2.45 Million Public Offering
Wuxi, China, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (the “Company”) today announced the closing of a
About this update from Park Ha Biological Technology Co., Ltd.
[{"type":"text","content":"Wuxi, China, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (the “Company”) today announced the closing of a best-efforts follow-on public offering of 21,875,000 units (each a “Unit”) at an offering price of US$0.112 per Unit. Each Unit consists of one Class A ordinary share of the Company, par value US$0.00002 per share (each, a “Class A Ordinary Share”) and one warrant to purchase one Class A Ordinary Share, or up to nine Class A Ordinary Shares pursuant to the alternative cashless exercise mechanism described therein (each, a “Warrant”). Each Warrant has an exercise price of US$0.112 per Class A Ordinary Share and is exercisable beginning on the issuance date and ending on the one-year anniversary of the issuance date. Gross proceeds to the Company, before deducting placement agent’s commissions and other offering expenses, were approximately US$2.45 million. The Company intends to use the net proceeds of the Offering for the expansion of directly operated stores in China, and the specific allocation of net proceeds to each market will be based on market conditions. D. Boral Capital LLC acted as the Sole Placement Agent for the Offering. A registration statement on Form F-1, as amended (File No. 333- 290410), relating to the Offering was filed with the U.S. Securities and Exchange Commission (the “SEC”) and was declared effective by the SEC on January 26, 2026. The Offering was made only by means of a prospectus, forming part of the effective registration statement. A copy of the final prospectus relating to the Offering has been filed with the SEC and is available on the SEC’s website at www.sec.gov. Copies of the prospectus may be obtained from D. Boral Capital LLC at [email protected], or by calling +1 (212) 970-5150. About Park Ha Biological Technology Co., Ltd. Established in 2016, Park Ha Biological Technology Co., Ltd. is primarily engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions under the proprietary brand “Park Ha”, with a commitment to providing cost-effective solutions to skin problems and improving the confidence of women in need of skin treatment. As of April 30, 2025, the Company has three directly operated stores and 39 franchisees, of which 38 and one operate under the store name “Park Ha” and “Gen...